RESOPHARMA
- Company typePrivate
- Founded1991
- HeadquartersParis, France
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
RESOPHARMA firmographics
Firmographics- Name
- RESOPHARMA
- Legal name
- RPLUS SANTE
- Website
- https://resopharma.fr
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
RESOPHARMA industry classification
Industry- Product category
- Healthcare Claims Management Software
- NAICS
- Computer Systems Design and Related Services (54151), Insurance Agencies and Brokerages (524210)
- SIC
- Services-Computer Programming, Data Processing, Etc. (7370), Services-Health Services (8000)
- akta.pro primary industry
- Interoperability Standards, Profiles & Implementation (HL7/FHIR/IHE) (HLACABAA)
Keywords
Where RESOPHARMA is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
RESOPHARMA business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Subscription services for teletransmission (FSE): Healthcare professionals subscribe to Résopharma's teletransmission platform to send electronic healthcare claims to insurance organizations. Revenue is generated through recurring subscription fees for access to the OCT (Organisme Concentrateur Technique) platform, including FSE transmission, ART (accusé de réception), and routing to AMO and AMC organizations.
- Résobank bank reconciliation service: Complementary paid service for automatic bank statement reconciliation, bundled with teletransmission subscription. Includes ARCH+ 24-month archiving capability. Revenue model is subscription-based as part of the overall service package.
- TransRIB PLUS+ (direct mail notification): Premium service for new practitioners or those changing bank details, involving direct postal notification to all historical payer organizations. Pricing is unit-based, dependent on the number of letters to be sent. Cost varies per practitioner based on transmission history analysis.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | TransRIB PLUS+ — Direct mail notification to all historical payer organizations |
| Subscription | Annual | Annuaire RIB-TP (basic listing) — included with teletransmission subscription |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
RESOPHARMA product offering
Product offeringCore offering
RESOPHARMA operates as a certified Organisme Concentrateur Technique (OCT) since 1991, providing an integrated electronic healthcare claims management platform for French healthcare professionals. Its core service, Télétransmission des FSE, electronically routes healthcare claims (Feuilles de Soins Électroniques) to all mandatory (AMO) and complementary (AMC) health insurance organizations in real time. The platform is complemented by Résobank bank reconciliation, TransRIB/Annulaire RIB-TP practitioner directory, and Résodroits/Visiodroits portal for complementary coverage verification.
Product overview
RESOPHARMA operates as a Technical Concentrator Organization (OCT) providing a platform-based suite of electronic healthcare claim management services. The core offering is the Télétransmission des FSE service, which handles electronic transmission of healthcare claims to mandatory and complementary insurance organizations. This is complemented by RESOBANK for bank reconciliation, TransRIB for insurance organism directory services, and Résodroits for accessing complementary coverage rights. Additional services include ARCH+ archiving, ART/ART+ acknowledgment features, and an online subscriber portal (Espace Abonné) with a new unified Rplus Santé portal launching in 2026. The platform primarily serves pharmacies, laboratories, medical device providers, opticians, physiotherapists, ambulance services, nurses, dentists, and physicians across France.
Differentiator
Problem solved
Functional benefit
Brands
- Résobank: Banking reconciliation service for healthcare professionals to match bank transfers from insurance organizations with electronic payment notices.
- TransRIB
- RésoDroits
- Résoflux
Products and services
- Télétransmission des FSE (Feuilles de Soins Électroniques) Core electronic transmission service that enables healthcare professionals (pharmacies, labs, opticians, doctors, nurses, etc.) to submit healthcare claims (FSE) in real time to all mandatory and complementary French health insurance organizations via the OCT platform. Handles batch control, flow splitting by recipient, and daily delivery to all organizations.
- Résobank Bank reconciliation service that automatically matches electronic payment notifications (RSP/Noémie returns) from insurance organizations with actual bank transfers (VRT) received at the healthcare professional's bank. Bundled with ARCH+ 24-month invoice archiving.
- TransRIB Service that registers healthcare professional bank details (RIB) in a secured directory (Annuaire RIB-TP) accessible by health insurers, enabling automatic notification of practitioner banking and address details to over 3,000 complementary insurers and AMO/AMC organizations when practitioners join or change details.
- Résodroits Unified web portal providing standardized access to complementary health insurance (AMC) rights data using the Visiodroits XML standard. Allows pharmacists to retrieve patient coverage dates and reimbursement rates in real time directly from 53 connected complementary insurer platforms.
- Espace Abonné / Nouveau Portail Client Rplus Santé
Quantifiable outcome
- Average insurance payment delay of 4–5 days after claim submission
- +2 more outcomes
Companies that use RESOPHARMA
Customer profileSegments2 records
Ideal customer profiles2 records
RESOPHARMA technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature5 records
RESOPHARMA partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- 107 health insurance organizations (AMO/AMC) registered in Annuaire RIB-TPcoreOver 107 health insurance organizations — including mandatory insurers (AMO) and complementary insurers (AMC) — are registered to consult the Annuaire RIB-TP directory maintained by Résopharma. This enables healthcare professionals to automatically update their banking and address details with these insurers. Partners include AXA, ALLIANZ, GROUPAMA, HARMONIE MUTUELLE, HENNER, GMF, MAAF, MMA, GAN, LA MONDIALE, and many others.
- 53 complementary health insurers (AMC) subscribed to Visiodroits via Résodroitscore53 complementary health insurance organizations are connected to the Résodroits portal via the Visiodroits XML standard, enabling real-time retrieval of patient coverage dates and reimbursement rates by pharmacists. Participating insurers include ALMERYS, CARTE BLANCHE, VIAMEDIS, GENERATION, HENNER, ACM, ACTIL, ALLIANZ, APGIS, AXA, GMF, GROUPAMA, MMA, MUTA SANTE, and others.
- Banks under convention with Résopharma (for Résobank VRT retrieval)coreRésopharma has established banking conventions with partner banks that agree to transmit electronic bank transfer records (VRT) to Résopharma for the Résobank reconciliation service. Healthcare professionals must give Résopharma a mandate to retrieve their bank statements from their bank. The list of conventioned banks is available on the Résopharma website.
Scale indicators8 records
Recent moves5 records
Expansion highlights4 records
RESOPHARMA competitors and assessment
Company assessmentDirect peers
- Equasens (Pharmagest): Equasens (formerly Pharmagest Group) is the leading French vendor of pharmacy management software and EDI/teletransmission services for community pharmacies. It is the most direct competitor to RESOPHARMA in pharmacist FSE teletransmission and complementary-insurer connectivity.
- Wallace (Groupe Lafiwin): Wallace is a French vendor of pharmacy management and teletransmission solutions serving community pharmacies. It is a direct competitor to RESOPHARMA in the same OCT / FSE teletransmission segment.
- Alliadis (Pharmatic): Alliadis is a French IT provider focused on pharmacy and healthcare-professional software with EDI/teletransmission services. It directly competes with RESOPHARMA for the same pharmacy subscriber base and payer connectivity.
Broad incumbents
- Cegedim: Cegedim is a major French healthcare IT group providing EDI, payer connectivity, and practice management software to pharmacies and physicians. It competes with RESOPHARMA in OCT/teletransmission services for healthcare professionals and offers a broader portfolio.
- CompuGroup Medical: CompuGroup Medical is a large European healthcare IT vendor with a French subsidiary (CGM France) offering physician and pharmacy software plus teletransmission. Comparable to RESOPHARMA as a competing OCT-adjacent provider serving similar French healthcare-professional customers.
- Dedalus: Dedalus is a major European healthcare IT vendor with a French presence delivering interoperability, EHR, and laboratory information systems. It competes in the broader French health-data exchange market where RESOPHARMA operates its OCT platform.
- Maincare Solutions: Maincare Solutions (a DOCAPOST subsidiary) provides hospital information systems and health-data exchange in France. It overlaps with RESOPHARMA in healthcare data interoperability and serves some of the same payer-provider integration use cases.
- Softway Medical: Softway Medical supplies hospital and healthcare IT solutions in France, including interoperability and integration layers relevant to RESOPHARMA's OCT business. Comparable as a French health-IT incumbent in payer-provider data exchange.
- Enovacom (Orange Business / Orange Healthcare): Enovacom, part of Orange Healthcare, provides healthcare interoperability, EHR integration, and data-exchange platforms in France. It overlaps with RESOPHARMA in health-data EDI and complementary-insurer connectivity infrastructure.
Others
- Pro Santé Connect (ANS): Pro Santé Connect is the French national identity provider for healthcare professionals, operated by the Agence du Numérique en Santé. It is an enabling layer that RESOPHARMA already integrates for authentication, rather than a competitor, but shapes the regulatory and authentication framework around French OCT operations.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
RESOPHARMA social profiles
Digital presenceRESOPHARMA compliance and trust
Trust signalCompliance2 records
RESOPHARMA financial estimates
Financial estimateRevenue estimate
Valuation estimate
RESOPHARMA leadership team
Management profileNumber of profiles
Profiles1 record
RESOPHARMA funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RESOPHARMA M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RESOPHARMA
What does RESOPHARMA do?
RESOPHARMA operates as a certified Organisme Concentrateur Technique (OCT) since 1991, providing an integrated electronic healthcare claims management platform for French healthcare professionals. Its core service, Télétransmission des FSE, electronically routes healthcare claims (Feuilles de Soins Électroniques) to all mandatory (AMO) and complementary (AMC) health insurance organizations in real time. The platform is complemented by Résobank bank reconciliation, TransRIB/Annulaire RIB-TP practitioner directory, and Résodroits/Visiodroits portal for complementary coverage verification.
Is RESOPHARMA a public or private company?
RESOPHARMA is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was RESOPHARMA founded?
RESOPHARMA was founded in 1991. It employs 11 to 50 people.
Where is RESOPHARMA based?
RESOPHARMA is headquartered in Paris, France, in the Europe region.
How does RESOPHARMA make money?
Three revenue lines are on record. Subscription services for teletransmission (FSE) is the primary driver. The others are Résobank bank reconciliation service and transRIB PLUS+ (direct mail notification).
Who are RESOPHARMA's main competitors?
Direct peers on record are Equasens (Pharmagest), Wallace (Groupe Lafiwin) and Alliadis (Pharmatic). Broad incumbents are Cegedim, CompuGroup Medical, Dedalus, Maincare Solutions, Softway Medical and Enovacom (Orange Business / Orange Healthcare). Pro Santé Connect (ANS) is listed as an others.
Does RESOPHARMA have an API?
No public API is recorded for RESOPHARMA.
What industry is RESOPHARMA in?
RESOPHARMA's product category is Healthcare Claims Management Software. Its primary akta.pro industry code is HLACABAA, Interoperability Standards, Profiles & Implementation (HL7/FHIR/IHE). Its NAICS code is 54151 and its SIC code is 7370.